
Opinion|Videos|August 23, 2024
Role of Biologics in Dermatological Care
A key opinion leader examines how the introduction of biologic therapies revolutionized atopic dermatitis treatment, addressing strategies to manage patients' concerns about needles and injections.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How have the emergence of biologics changed the treatment landscape of these diseases caused by an overactive immune response?
- How do you approach presenting monoclonal antibody treatments to patients or caregivers who have an apprehension of needles or injections? What strategies do you use to alleviate their concerns and gain their trust in proceeding with this preferred treatment option?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
2025 Hypertension Guideline Updates Presented at AHA Scientific Sessions
2
Inside the VA’s Hub-and-Spoke Model for Multiple Sclerosis Care: Rebecca Spain, MD
3
CD19 CAR T-Cell Therapy Shows Promising Activity in Richter Transformation
4
New Evidence Strengthens Case for Modifiable Risk Factors in Multiple Sclerosis
5

















































